Bortezomib, doxorubicin and dexamethasone association is an effective option for plasma cell leukemia induction therapy

被引:20
作者
Al-Nawakil, Chadi [1 ,2 ]
Tamburini, Jerome [2 ]
Bardet, Valerie [2 ,3 ]
Chapuis, Nicolas [2 ,3 ]
Bourry, Edward [4 ,5 ]
Roux, Christian [2 ,6 ]
Park, Sophie [2 ]
Choquet, Sylvain [4 ,7 ]
Dreyfus, Francois [2 ]
Bouscary, Didier [2 ]
机构
[1] Hop Cochin, AP HP, UF Hematol, Serv Med Interne, F-75014 Paris, France
[2] Univ Paris 05, Fac Med Rene Descartes, Paris, France
[3] Hop Cochin, Serv Hematol Biol, F-75014 Paris, France
[4] Univ Paris 06, Paris, France
[5] Hop La Pitie Salpetriere, Serv Nephrol, Paris, France
[6] Hop Cochin, Serv Rhumatol, F-75014 Paris, France
[7] Hop La Pitie Salpetriere, Serv Hematol, Paris, France
关键词
D O I
10.1080/10428190802290660
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2012 / 2014
页数:3
相关论文
共 13 条
[1]   Stem-cell transplantation for multiple myeloma in the era of novel drugs [J].
Bensinger, William .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (03) :480-492
[2]   Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen [J].
Bertheau, Philippe ;
Turpin, Elisabeth ;
Rickman, David S. ;
Espie, Marc ;
de Reynies, Aurelien ;
Feugeas, Jean-Paul ;
Plassa, Louis-Francois ;
Soliman, Hany ;
Varna, Mariana ;
de Roquancourt, Anne ;
Lehmann-Che, Jacqueline ;
Beuzard, Yves ;
Marty, Michel ;
Misset, Jean-Louis ;
Janin, Anne ;
de The, Hugues .
PLOS MEDICINE, 2007, 4 (03) :585-594
[3]   Significantly better prognosis for patients with primary plasma cell leukemia than for patients with secondary plasma cell leukemia [J].
Cha, Choong Hwan ;
Park, Chan Jeoung ;
Huh, Joo Ryung ;
Chi, Hyun Sook ;
Suh, Cheol Won ;
Kang, Yoon Koo .
ACTA HAEMATOLOGICA, 2007, 118 (03) :178-182
[4]   Primary plasma cell leukaemia:: a report of 18 cases [J].
Costello, R ;
Sainty, D ;
Bouabdallah, R ;
Fermand, JP ;
Delmer, A ;
Diviné, M ;
Marolleau, JP ;
Gastaut, JA ;
Olive, D ;
Rousselot, P ;
Chaïbi, P .
LEUKEMIA RESEARCH, 2001, 25 (02) :103-107
[5]   International uniform response criteria for multiple myeloma [J].
Durie, B. G. M. ;
Harousseau, J-L ;
Miguel, J. S. ;
Blade, J. ;
Barlogie, B. ;
Anderson, K. ;
Gertz, M. ;
Dimopoulos, M. ;
Westin, J. ;
Sonneveld, P. ;
Ludwig, H. ;
Gahrton, G. ;
Beksac, M. ;
Crowley, J. ;
Belch, A. ;
Boccadaro, M. ;
Turesson, I. ;
Joshua, D. ;
Vesole, D. ;
Kyle, R. ;
Alexanian, R. ;
Tricot, G. ;
Attal, M. ;
Merlini, G. ;
Powles, R. ;
Richardson, P. ;
Shimizu, K. ;
Tosi, P. ;
Morgan, G. ;
Rajkumar, S. V. .
LEUKEMIA, 2006, 20 (09) :1467-1473
[6]   Bortezomib is effective in primary plasma cell leukemia [J].
Finnegan, Damian P. J. ;
Kettle, Paul ;
Drake, Mary ;
Matthews, Christine ;
Alexander, H. Denis ;
Popat, Rakesh ;
Cavanagh, Jamie D. ;
Wachsman, William ;
Morris, T. C. M. .
LEUKEMIA & LYMPHOMA, 2006, 47 (08) :1670-1673
[7]   Managing plasma cell leukemia [J].
Gertz, Morie A. .
LEUKEMIA & LYMPHOMA, 2007, 48 (01) :5-6
[8]   Response of primary plasma cell leukemia to the combination of bortezomib and dexamethasone: Do specific cytogenetic and immunophenotypic characteristics influence treatment outcome? [J].
Katodritou, Eirini ;
Verrou, Evgenia ;
Gastari, Vassiliki ;
Hadjiaggelidou, Christina ;
Terpos, Evangelos ;
Zervas, Konstantinos .
LEUKEMIA RESEARCH, 2008, 32 (07) :1153-1156
[9]   Combination chemotherapy with bortezomib, cyclophosphamide and dexamethasone may be effective for plasma cell leukemia [J].
Kim, Seok Jin ;
Kim, Jeeyong ;
Cho, Yunjung ;
Seo, Bo Kyoung ;
Kim, Byung Soo .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (05) :382-384
[10]   Efficacy and safety of bortezomib in patients with plasma cell leukemia [J].
Musto, Pellegrino ;
Rossini, Fausto ;
Gay, Francesca ;
Pitini, Vincenzo ;
Guglielmelli, Tommasina ;
D'Arena, Giovanni ;
Ferrara, Felicetto ;
Filardi, Nunzio ;
Guariglia, Roberto ;
Palumbo, Antonio .
CANCER, 2007, 109 (11) :2285-2290